An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Watkins, A James ^a   Hamoudi, Rifat A ^a   Zeng, Naiyan ^a   Yan, Qingguo ^a,b   Huang, Yuanxue ^a   Liu, Hongxiang ^c   Zhang, Jianzhong ^d   Braggio, Esteban ^e   Fonseca, Rafael ^e   de Leval, Laurence ^f   Isaacson, Peter G ^g   Wotherspoon, Andrew ^h   McPhail, Ellen D ⁱ   Dogan, Ahmet ⁱ   Du, Ming Qing ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d 306 HOSPITAL OF PLA   (China)

^e MAYO CLINIC   (United States)

^f UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 5; MICRORNA; MICRORNA 182; MICRORNA 183; MICRORNA 96; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME DELETION 7Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRF5 GENE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; SOMATIC MUTATION; SPLENIC MARGINAL ZONE LYMPHOMA;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOME, HUMAN; HETEROZYGOTE; HUMANS; INTERFERON REGULATORY FACTORS; LYMPHOMA, B-CELL, MARGINAL ZONE; MICRORNAS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; SPLENIC NEOPLASMS;

EID: 84866431776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044997     Document Type: Article

References (33)

1. Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C,et al. Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. editors. WHO Classification of Tumous of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer 2008: 185-187.
2. Mateo M, Mollejo M, Villuendas R, Algara P, Sanchez-Beato M, et al. (1999) 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 154: 1583-1589.
3. Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D, (2003) Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 36: 57-69.
4. Watkins AJ, Huang Y, Ye H, Chanudet E, Johnson N, et al. (2010) Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. J Pathol 220: 461-474.
5. Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, et al. (2012) Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol 25: 651-660.
6. Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, et al. (2007) MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 21: 2547-2549.
7. Expression profiling-best practices for data generation and interpretation in clinical trials (2004 Nat Rev Genet. 5: 229-237.
8. Pepper SD, Saunders EK, Edwards LE, Wilson CL, Miller CJ, (2007) The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics 8: 273.
9. Hamoudi RA, Appert A, Ye H, Ruskone-Fourmestraux A, Streubel B, et al. (2010) Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia 24: 1487-1497.
10. Sabbah C, Mazo G, Paccard C, Reyal F, Hupe P, (2011) SMETHILLIUM: spatial normalization method for Illumina infinium HumanMethylation BeadChip. Bioinformatics 27: 1693-1695.
11. Pan LX, Diss TC, Peng HZ, Isaacson PG, (1994) Clonality analysis of defined B-cell populations in archival tissue sections using microdissection and the polymerase chain reaction. Histopathology 24: 323-327.
12. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, et al. (2007) Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A 104: 3402-3407.
13. Wieczorek S, Holle JU, Muller S, Fricke H, Gross WL, et al. (2010) A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med (Berl) 88: 413-421.
14. Troen G, Nygaard V, Jenssen TK, Ikonomou IM, Tierens A, et al. (2004) Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn 6: 297-307.
15. Thieblemont C, Nasser V, Felman P, Leroy K, Gazzo S, et al. (2004) Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 103: 2727-2737.
16. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, et al. (2005) Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 106: 1831-1838.
17. Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, et al. (2012) MicroRNA expression profile in splenic marginal zone lymphoma. Br J Haematol 156: 279-281.
18. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, et al. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
19. Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, et al. (2009) Identification of the human mature B cell miRNome. Immunity 30: 744-752.
20. Peveling-Oberhag J, Crisman G, Schmidt A, Doring C, Lucioni M, et al. (2012) Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia.
21. Varol N, Konac E, Gurocak OS, Sozen S, (2011) The realm of microRNAs in cancers. Mol Biol Rep 38: 1079-1089.
22. Saus E, Soria V, Escaramis G, Vivarelli F, Crespo JM, et al. (2010) Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum Mol Genet 19: 4017-4025.
23. Winter J, Jung S, Keller S, Gregory RI, Diederichs S, (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228-234.
24. Bai AH, Milde T, Remke M, Rolli CG, Hielscher T, et al. (2011) MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol.
25. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, et al. (2011) The miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem.
26. Zhang L, Liu T, Huang Y, Liu J, (2011) microRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein. Int J Mol Med 28: 381-388.
27. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, et al. (2011) miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 41: 210-220.
28. Sun Y, Fang R, Li C, Li L, Li F, et al. (2010) Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 396: 501-507.
29. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104: 6758-6763.
30. Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, et al. (2011) Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 17: 1535-1545.
31. Vanaja DK, Ehrich M, Van den BD, Cheville JC, Karnes RJ, et al. (2009) Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 27: 549-560.
32. Kim JH, Jung EJ, Lee HS, Kim MA, Kim WH, (2009) Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma. Oncol Rep 21: 1251-1259.
33. Imura M, Yamashita S, Cai LY, Furuta J, Wakabayashi M, et al. (2006) Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines. Cancer Lett 241: 213-220.